New Delhi, Jan. 21 -- Dr Reddy's Laboratories on Wednesday, January 21, posted a 14% decline in the consolidated net profit during the third quarter of the financial year 2025-26 (Q3FY26).

The pharma major, part of the Nifty 50 index, said its net profit stood at Rs.1209.8 crore in Q3 FY26 as against Rs.1413.3 crore in the same period a year ago. However, its revenue from operations rose 4.4% to Rs.8726.8 crore in the quarter under review compared with Rs.8358.6 crore in Q3FY25.

More to come.

Published by HT Digital Content Services with permission from MINT....